Adma Biologics reported $239.8M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Adamis Pharmaceuticals ADMP:US 27.79M 7.41M
Adma Biologics ADMA:US $ 239.8M 31.07M
Agile Therapeutics AGRX:US 14.35M 9.57M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Biocryst Pharmaceuticals BCRX:US $ 511.71M 54.42M
China Cord Blood CO:US 6.78B 133.74M
Dynavax Technologies DVAX:US $ 940.52M 32.01M
Minerva Neurosciences NERV:US $ 55.7M 6.5M
Novavax NVAX:US $ 2347.41M 192.29M
Omeros OMER:US $ 210.22M 37.67M
Takeda 4502:JP Y 2593642M 115749M